The next-generation Closed-System Drug-Transfer Device (CSTD) from BD that advances hazardous drug protection
Safety. Performance. Ergonomics. Ease of use. We've optimized every component, and the result is a CSTD with design innovations that advance hazardous drug safety. The BD PhaSeal™ Optima system meets the requirements of the NIOSH IPA draft CSTD-test protocol‡, a robust test protocol applicable to barrier-type closed system drug transfer devices.1,2
Airtight
Every component is designed with no inlets or air exchange for completely airtight hazardous drug transfers.
Demonstrated
The BD PhaSeal™ Optima system prevents microbial ingress for up to 168 hours and 10 penetrations*†
Efficient
The BD PhaSeal™ Optima system minimizes residual drug loss in vials compared to other similar system.
User-validated
Feedback from longstanding CSTD users and traditional technique users guided us to optimize and innovate the design.
Safety
Performance
Ergonomics
Ease of use
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs.
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
Notes
‡2015
*Within an ISO Class V environment following aseptic technique.
†The ability to prevent microbial ingress for up to 168 hours should not be interpreted as modifying, extending or superseding a manufacturer's labeling recommendations for the storage and expiration dating of the drug vial. Refer to drug manufacturer’s recommendations and USP compounding guidelines for shelf life and sterility information.
References
BD-20816